Stifel Financial Corp Acquires 471 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)

Stifel Financial Corp increased its holdings in shares of UFP Technologies, Inc. (NASDAQ:UFPT) by 19.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,878 shares of the industrial products company’s stock after buying an additional 471 shares during the period. Stifel Financial Corp’s holdings in UFP Technologies were worth $911,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Wasatch Advisors LP grew its holdings in UFP Technologies by 65.4% during the 3rd quarter. Wasatch Advisors LP now owns 420,549 shares of the industrial products company’s stock worth $133,188,000 after acquiring an additional 166,262 shares during the period. Congress Asset Management Co. boosted its position in shares of UFP Technologies by 0.4% in the 3rd quarter. Congress Asset Management Co. now owns 246,303 shares of the industrial products company’s stock worth $78,004,000 after purchasing an additional 986 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of UFP Technologies by 2.6% during the second quarter. Massachusetts Financial Services Co. MA now owns 105,118 shares of the industrial products company’s stock worth $27,737,000 after purchasing an additional 2,699 shares during the period. Mountain Pacific Investment Advisers LLC increased its holdings in UFP Technologies by 0.3% in the third quarter. Mountain Pacific Investment Advisers LLC now owns 92,976 shares of the industrial products company’s stock valued at $29,445,000 after purchasing an additional 238 shares during the last quarter. Finally, Geneva Capital Management LLC increased its holdings in UFP Technologies by 0.3% in the third quarter. Geneva Capital Management LLC now owns 80,362 shares of the industrial products company’s stock valued at $25,450,000 after purchasing an additional 243 shares during the last quarter. 87.28% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded UFP Technologies from a “sell” rating to a “hold” rating in a report on Tuesday.

Insider Activity at UFP Technologies

In related news, CEO R Jeffrey Bailly sold 12,533 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $346.46, for a total value of $4,342,183.18. Following the completion of the transaction, the chief executive officer now directly owns 31,194 shares in the company, valued at approximately $10,807,473.24. The trade was a 28.66 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Jason Holt sold 146 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $342.69, for a total transaction of $50,032.74. Following the sale, the vice president now owns 6,721 shares in the company, valued at $2,303,219.49. This trade represents a 2.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,326 shares of company stock worth $4,620,154 in the last quarter. Corporate insiders own 6.17% of the company’s stock.

UFP Technologies Trading Down 0.2 %

UFPT opened at $252.43 on Tuesday. The firm’s fifty day moving average is $294.45 and its two-hundred day moving average is $301.65. The firm has a market cap of $1.94 billion, a PE ratio of 36.01 and a beta of 0.99. UFP Technologies, Inc. has a twelve month low of $152.43 and a twelve month high of $366.41. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.43 and a current ratio of 2.57.

About UFP Technologies

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.